{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:00:58Z","timestamp":1778497258584,"version":"3.51.4"},"reference-count":103,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,10,13]]},"DOI":"10.7759\/cureus.47004","type":"journal-article","created":{"date-parts":[[2023,10,14]],"date-time":"2023-10-14T05:09:36Z","timestamp":1697260176000},"source":"Crossref","is-referenced-by-count":2,"title":["Diagnostic Efficacy and Clinical Relevance of Artificial Intelligence in Detecting Cognitive Decline"],"prefix":"10.7759","author":[{"given":"Ali A","family":"Mohamed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oge","family":"Marques","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"World population ageing 2020. (2020). https.\/\/www.un.org\/development\/desa\/pd\/sites\/www.un.org.development.desa.pd\/files\/files\/documents\/2020\/Sep\/un_pop_202...."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clineuro.2019.105575","article-title":"Treatable causes of adult-onset rapid cognitive impairment","volume":"187","author":"Wang S","year":"2019","unstructured":"Wang S, Zhang J, Liang J, Song H, Ji X. Treatable causes of adult-onset rapid cognitive impairment. Clin Neurol Neurosurg. 2019, 187:10.1016\/j.clineuro.2019.105575","journal-title":"Clin Neurol Neurosurg"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.070795","article-title":"Diagnosis and treatment of dementia: introduction. Introducing a series based on the Third Canadian Consensus Conference on the diagnosis and treatment of dementia","volume":"178","author":"Chertkow H","year":"2008","unstructured":"Chertkow H. Diagnosis and treatment of dementia: introduction. Introducing a series based on the Third Canadian Consensus Conference on the diagnosis and treatment of dementia. CMAJ. 2008, 178:316-21. 10.1503\/cmaj.070795","journal-title":"CMAJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1093\/arclin\/acu034","article-title":"Mild cognitive impairment and dementia: definitions, diagnosis, and treatment","volume":"29","author":"Duff K","year":"2014","unstructured":"Duff K. Mild cognitive impairment and dementia: definitions, diagnosis, and treatment. Arch Clin Neuropsychol. 2014, 29:691-2. 10.1093\/arclin\/acu034","journal-title":"Arch Clin Neuropsychol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/da.20874","article-title":"Dissociative disorders in DSM-5","volume":"28","author":"Spiegel D","year":"2011","unstructured":"Spiegel D, Loewenstein RJ, Lewis-Fern\u00e1ndez R, et al.. Dissociative disorders in DSM-5. Depress Anxiety. 2011, 28:824-52. 10.1002\/da.20874","journal-title":"Depress Anxiety"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.105.014779","article-title":"Progression of mild cognitive impairment to dementia: a challenge to current thinking","volume":"189","author":"Busse A","year":"2006","unstructured":"Busse A, Angermeyer MC, Riedel-Heller SG. Progression of mild cognitive impairment to dementia: a challenge to current thinking. Br J Psychiatry. 2006, 189:399-404. 10.1192\/bjp.bp.105.014779","journal-title":"Br J Psychiatry"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-014-9276-3","article-title":"Genetics and underlying pathology of dementia","volume":"25","author":"Ferencz B","year":"2015","unstructured":"Ferencz B, Gerritsen L. Genetics and underlying pathology of dementia. Neuropsychol Rev. 2015, 25:113-24. 10.1007\/s11065-014-9276-3","journal-title":"Neuropsychol Rev"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.AD19038BR1C","article-title":"Epidemiology and pathophysiology of dementia-related psychosis","volume":"81","author":"Aarsland D","year":"2020","unstructured":"Aarsland D. Epidemiology and pathophysiology of dementia-related psychosis. J Clin Psychiatry. 2020, 81:10.4088\/JCP.AD19038BR1C","journal-title":"J Clin Psychiatry"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.7748\/ns.29.37.37.e9405","article-title":"Dementia: definitions and types","volume":"29","author":"Dening T","year":"2015","unstructured":"Dening T, Sandilyan MB. Dementia: definitions and types. Nurs Stand. 2015, 29:37-42. 10.7748\/ns.29.37.37.e9405","journal-title":"Nurs Stand"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/0019-5545.117131","article-title":"Diagnostic and statistical manual of mental disorders 5: a quick glance","volume":"55","author":"Vahia VN","year":"2013","unstructured":"Vahia VN. Diagnostic and statistical manual of mental disorders 5: a quick glance. Indian J Psychiatry. 2013, 55:220-3. 10.4103\/0019-5545.117131","journal-title":"Indian J Psychiatry"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.5853\/jos.2014.16.1.18","article-title":"Recent updates on subcortical ischemic vascular dementia","volume":"16","author":"Roh JH","year":"2014","unstructured":"Roh JH, Lee JH. Recent updates on subcortical ischemic vascular dementia. J Stroke. 2014, 16:18-26. 10.5853\/jos.2014.16.1.18","journal-title":"J Stroke"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010783.pub3","article-title":"Mini-mental state examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI)","volume":"7","author":"Arevalo-Rodriguez I","year":"2021","unstructured":"Arevalo-Rodriguez I, Smailagic N, Roqu\u00e9-Figuls M, et al.. Mini-mental state examination (MMSE) for the early detection of dementia in people with mild cognitive impairment (MCI). Cochrane Database Syst Rev. 2021, 7:10.1002\/14651858.CD010783.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2018.02.018","article-title":"NIA-AA research framework: toward a biological definition of Alzheimer's disease","volume":"14","author":"Jack CR Jr","year":"2018","unstructured":"Jack CR Jr, Bennett DA, Blennow K, et al.. NIA-AA research framework: toward a biological definition of Alzheimer's disease. Alzheimers Dement. 2018, 14:535-62. 10.1016\/j.jalz.2018.02.018","journal-title":"Alzheimers Dement"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1111\/ggi.12259","article-title":"Early detection of dementia in the community under a community-based integrated care system","volume":"14","author":"Maki Y","year":"2014","unstructured":"Maki Y, Yamaguchi H. Early detection of dementia in the community under a community-based integrated care system. Geriatr Gerontol Int. 2014, 14:2-10. 10.1111\/ggi.12259","journal-title":"Geriatr Gerontol Int"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1017\/ipm.2018.4","article-title":"The Lancet Commission on dementia prevention, intervention, and care: a call for action","volume":"36","author":"Orgeta V","year":"2019","unstructured":"Orgeta V, Mukadam N, Sommerlad A, Livingston G. The Lancet Commission on dementia prevention, intervention, and care: a call for action. Ir J Psychol Med. 2019, 36:85-8. 10.1017\/ipm.2018.4","journal-title":"Ir J Psychol Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/jpm11080688","article-title":"Tele-neuropsychological assessment of Alzheimer's disease","volume":"11","author":"Carotenuto A","year":"2021","unstructured":"Carotenuto A, Traini E, Fasanaro AM, Battineni G, Amenta F. Tele-neuropsychological assessment of Alzheimer's disease. J Pers Med. 2021, 11:10.3390\/jpm11080688","journal-title":"J Pers Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11112103","article-title":"Improved Alzheimer's disease detection by MRI using multimodal machine learning algorithms","volume":"11","author":"Battineni G","year":"2021","unstructured":"Battineni G, Hossain MA, Chintalapudi N, Traini E, Dhulipalla VR, Ramasamy M, Amenta F. Improved Alzheimer's disease detection by MRI using multimodal machine learning algorithms. Diagnostics (Basel). 2021, 11:10.3390\/diagnostics11112103","journal-title":"Diagnostics (Basel)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","author":"McKhann GM","year":"2011","unstructured":"McKhann GM, Knopman DS, Chertkow H, et al.. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011, 7:263-9. 10.1016\/j.jalz.2011.03.005","journal-title":"Alzheimers Dement"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.0435","article-title":"Screening for cognitive impairment in older adults: US Preventive Services Task Force recommendation statement","volume":"323","author":"Owens DK","year":"2020","unstructured":"Owens DK, Davidson KW, Krist AH, et al.. Screening for cognitive impairment in older adults: US Preventive Services Task Force recommendation statement. J Am Med Assoc. 2020, 323:757-63. 10.1001\/jama.2020.0435","journal-title":"J Am Med Assoc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117529","article-title":"Early detection of cognitive decline in mild cognitive impairment and Alzheimer's disease with a novel eye tracking test","volume":"427","author":"Tadokoro K","year":"2021","unstructured":"Tadokoro K, Yamashita T, Fukui Y, et al.. Early detection of cognitive decline in mild cognitive impairment and Alzheimer's disease with a novel eye tracking test. J Neurol Sci. 2021, 427:10.1016\/j.jns.2021.117529","journal-title":"J Neurol Sci"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-022-02237-w","article-title":"Developments in scalable strategies for detecting early markers of cognitive decline","volume":"12","author":"Whelan R","year":"2022","unstructured":"Whelan R, Barbey FM, Cominetti MR, Gillan CM, Rosick\u00e1 AM. Developments in scalable strategies for detecting early markers of cognitive decline. Transl Psychiatry. 2022, 12:10.1038\/s41398-022-02237-w","journal-title":"Transl Psychiatry"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2021.04.024","article-title":"A machine learning approach to screen for preclinical Alzheimer's disease","volume":"105","author":"Gaubert S","year":"2021","unstructured":"Gaubert S, Houot M, Raimondo F, et al.. A machine learning approach to screen for preclinical Alzheimer's disease. Neurobiol Aging. 2021, 105:205-16. 10.1016\/j.neurobiolaging.2021.04.024","journal-title":"Neurobiol Aging"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3390\/e22070733","article-title":"A deep learning approach for featureless robust quality assessment of intermittent atrial fibrillation recordings from portable and wearable devices","volume":"22","author":"Herraiz \u00c1H","year":"2020","unstructured":"Herraiz \u00c1H, Mart\u00ednez-Rodrigo A, Bertomeu-Gonz\u00e1lez V, Quesada A, Rieta JJ, Alcaraz R. A deep learning approach for featureless robust quality assessment of intermittent atrial fibrillation recordings from portable and wearable devices. Entropy (Basel). 2020, 22:10.3390\/e22070733","journal-title":"Entropy (Basel)"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328999210111211420","article-title":"Machine learning approaches in Parkinson's disease","volume":"28","author":"Landolfi A","year":"2021","unstructured":"Landolfi A, Ricciardi C, Donisi L, et al.. Machine learning approaches in Parkinson's disease. Curr Med Chem. 2021, 28:6548-68. 10.2174\/0929867328999210111211420","journal-title":"Curr Med Chem"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000768","article-title":"Machine learning, artificial intelligence and the prediction of dementia","volume":"35","author":"Merkin A","year":"2022","unstructured":"Merkin A, Krishnamurthi R, Medvedev ON. Machine learning, artificial intelligence and the prediction of dementia. Curr Opin Psychiatry. 2022, 35:123-9. 10.1097\/YCO.0000000000000768","journal-title":"Curr Opin Psychiatry"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/s21217259","article-title":"Transfer learning for Alzheimer's disease through neuroimaging biomarkers: a systematic review","volume":"21","author":"Agarwal D","year":"2021","unstructured":"Agarwal D, Marques G, de la Torre-D\u00edez I, Franco Martin MA, Garc\u00eda Zapira\u00edn B, Mart\u00edn Rodr\u00edguez F. Transfer learning for Alzheimer's disease through neuroimaging biomarkers: a systematic review. Sensors (Basel). 2021, 21:10.3390\/s21217259","journal-title":"Sensors (Basel)"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooab052","article-title":"Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review","volume":"4","author":"Kumar S","year":"2021","unstructured":"Kumar S, Oh I, Schindler S, Lai AM, Payne PR, Gupta A. Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review. JAMIA Open. 2021, 4:10.1093\/jamiaopen\/ooab052","journal-title":"JAMIA Open"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1109\/RBME.2019.2904488","article-title":"Harnessing the power of machine learning in dementia informatics research: issues, opportunities, and challenges","volume":"13","author":"Tsang G","year":"2020","unstructured":"Tsang G, Xie X, Zhou SM. Harnessing the power of machine learning in dementia informatics research: issues, opportunities, and challenges. IEEE Rev Biomed Eng. 2020, 13:113-29. 10.1109\/RBME.2019.2904488","journal-title":"IEEE Rev Biomed Eng"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1161\/STR.0b013e3182299496","article-title":"Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association","volume":"42","author":"Gorelick PB","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE, et al.. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association\/american stroke association. Stroke. 2011, 42:2672-713. 10.1161\/STR.0b013e3182299496","journal-title":"Stroke"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000009323","article-title":"Research criteria for the diagnosis of prodromal dementia with Lewy bodies","volume":"94","author":"McKeith IG","year":"2020","unstructured":"McKeith IG, Ferman TJ, Thomas AJ, et al.. Research criteria for the diagnosis of prodromal dementia with Lewy bodies. Neurology. 2020, 94:743-55. 10.1212\/WNL.0000000000009323","journal-title":"Neurology"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1002\/mds.24893","article-title":"Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines","volume":"27","author":"Litvan I","year":"2012","unstructured":"Litvan I, Goldman JG, Tr\u00f6ster AI, et al.. Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord. 2012, 27:349-56. 10.1002\/mds.24893","journal-title":"Mov Disord"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1037\/a0014001","article-title":"Emotion experience, expression, and regulation in Alzheimer's disease","volume":"24","author":"Henry JD","year":"2009","unstructured":"Henry JD, Rendell PG, Scicluna A, Jackson M, Phillips LH. Emotion experience, expression, and regulation in Alzheimer's disease. Psychol Aging. 2009, 24:252-7. 10.1037\/a0014001","journal-title":"Psychol Aging"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1080\/13825580600735085","article-title":"Emotional experience and facial expression in Alzheimer's disease","volume":"13","author":"Burton KW","year":"2006","unstructured":"Burton KW, Kaszniak AW. Emotional experience and facial expression in Alzheimer's disease. Neuropsychol Dev Cogn B Aging Neuropsychol Cogn. 2006, 13:636-51. 10.1080\/13825580600735085","journal-title":"Neuropsychol Dev Cogn B Aging Neuropsychol Cogn"},{"key":"ref34","article-title":"Facial expression in mild dementia of the Alzheimer type","volume":"8","author":"Smith MC","year":"1995","unstructured":"Smith MC. Facial expression in mild dementia of the Alzheimer type. Behav Neurol. 1995, 8:149-56.","journal-title":"Behav Neurol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.cobeha.2017.05.017","article-title":"Increased subjective experience of non-target emotions in patients with frontotemporal dementia and Alzheimer's disease","volume":"15","author":"Chen KH","year":"2017","unstructured":"Chen KH, Lwi SJ, Hua AY, Haase CM, Miller BL, Levenson RW. Increased subjective experience of non-target emotions in patients with frontotemporal dementia and Alzheimer's disease. Curr Opin Behav Sci. 2017, 15:77-84. 10.1016\/j.cobeha.2017.05.017","journal-title":"Curr Opin Behav Sci"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.neucom.2021.10.038","article-title":"A novel deep neural network-based emotion analysis system for automatic detection of mild cognitive impairment in the elderly","volume":"468","author":"Fei Z","year":"2022","unstructured":"Fei Z, Yang E, Yu L, Li X, Zhou H, Zhou W. A novel deep neural network-based emotion analysis system for automatic detection of mild cognitive impairment in the elderly. Neurocomputing. 2022, 468:468-10. 10.1016\/j.neucom.2021.10.038","journal-title":"Neurocomputing"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1186\/s12911-019-0974-x","article-title":"Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data","volume":"19","author":"Kang MJ","year":"2019","unstructured":"Kang MJ, Kim SY, Na DL, et al.. Prediction of cognitive impairment via deep learning trained with multi-center neuropsychological test data. BMC Med Inform Decis Mak. 2019, 19:10.1186\/s12911-019-0974-x","journal-title":"BMC Med Inform Decis Mak"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1109\/EMBC44109.2020.9175955","article-title":"Dual-task gait assessment and machine learning for early-detection of cognitive decline","volume":"2020","author":"Boettcher LN","year":"2020","unstructured":"Boettcher LN, Hssayeni M, Rosenfeld A, Tolea MI, Galvin JE, Ghoraani B. Dual-task gait assessment and machine learning for early-detection of cognitive decline. Annu Int Conf IEEE Eng Med Biol Soc. 2020, 2020:3204-7. 10.1109\/EMBC44109.2020.9175955","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.bspc.2020.102249","article-title":"Detection of mild cognitive impairment and Alzheimer's disease using dual-task gait assessments and machine learning","volume":"64","author":"Ghoraani B","year":"2021","unstructured":"Ghoraani B, Boettcher LN, Hssayeni MD, Rosenfeld A, Tolea MI, Galvin JE. Detection of mild cognitive impairment and Alzheimer's disease using dual-task gait assessments and machine learning. Biomed Signal Process Control. 2021, 64:10.1016\/j.bspc.2020.102249","journal-title":"Biomed Signal Process Control"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1016\/j.bspc.2022.103500","article-title":"AlzVNet: a volumetric convolutional neural network for multiclass classification of Alzheimer\u2019s disease through multiple neuroimaging computational approaches","volume":"74","author":"Goenka N","year":"2022","unstructured":"Goenka N, Tiwari S. AlzVNet: a volumetric convolutional neural network for multiclass classification of Alzheimer\u2019s disease through multiple neuroimaging computational approaches. Biomed Signal Process Control. 2022, 74:10.1016\/j.bspc.2022.103500","journal-title":"Biomed Signal Process Control"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2020.603179","article-title":"A 5-min cognitive task with deep learning accurately detects early Alzheimer's disease","volume":"12","author":"Almubark I","year":"2020","unstructured":"Almubark I, Chang LC, Shattuck KF, Nguyen T, Turner RS, Jiang X. A 5-min cognitive task with deep learning accurately detects early Alzheimer's disease. Front Aging Neurosci. 2020, 12:10.3389\/fnagi.2020.603179","journal-title":"Front Aging Neurosci"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci9090212","article-title":"Classification of Alzheimer's disease with and without Imagery using gradient boosted machines and ResNet-50","volume":"9","author":"Fulton LV","year":"2019","unstructured":"Fulton LV, Dolezel D, Harrop J, Yan Y, Fulton CP. Classification of Alzheimer's disease with and without Imagery using gradient boosted machines and ResNet-50. Brain Sci. 2019, 9:10.3390\/brainsci9090212","journal-title":"Brain Sci"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/s22030740","article-title":"An intelligent system for early recognition of Alzheimer's disease using neuroimaging","volume":"22","author":"Odusami M","year":"2022","unstructured":"Odusami M, Maskeli\u016bnas R, Dama\u0161evi\u010dius R. An intelligent system for early recognition of Alzheimer's disease using neuroimaging. Sensors (Basel). 2022, 22:10.3390\/s22030740","journal-title":"Sensors (Basel)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.00259","article-title":"Early detection of Alzheimer's disease using magnetic resonance imaging: a novel approach combining convolutional neural networks and ensemble learning","volume":"14","author":"Pan D","year":"2020","unstructured":"Pan D, Zeng A, Jia L, Huang Y, Frizzell T, Song X. Early detection of Alzheimer's disease using magnetic resonance imaging: a novel approach combining convolutional neural networks and ensemble learning. Front Neurosci. 2020, 14:10.3389\/fnins.2020.00259","journal-title":"Front Neurosci"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1016\/j.jksuci.2021.09.003","article-title":"An experimental analysis of different deep learning based models for Alzheimer\u2019s disease classification using brain magnetic resonance images","volume":"34","author":"Hazarika RA","year":"2022","unstructured":"Hazarika RA, Kandar D, Maji AK. An experimental analysis of different deep learning based models for Alzheimer\u2019s disease classification using brain magnetic resonance images. J King Saud Univ Comput Inf Sci. 2022, 34:8576-98. 10.1016\/j.jksuci.2021.09.003","journal-title":"J King Saud Univ Comput Inf Sci"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2017.06.027","article-title":"Identifying incipient dementia individuals using machine learning and amyloid imaging","volume":"59","author":"Mathotaarachchi S","year":"2017","unstructured":"Mathotaarachchi S, Pascoal TA, Shin M, et al.. Identifying incipient dementia individuals using machine learning and amyloid imaging. Neurobiol Aging. 2017, 59:80-90. 10.1016\/j.neurobiolaging.2017.06.027","journal-title":"Neurobiol Aging"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.procs.2020.01.049","article-title":"Effective diagnosis of Alzheimer\u2019s disease using modified decision tree classifier","volume":"165","author":"Naganandhini S","year":"2019","unstructured":"Naganandhini S, Shanmugavadivu P. Effective diagnosis of Alzheimer\u2019s disease using modified decision tree classifier. Procedia Comput Sci. 2019, 165:548-55. 10.1016\/j.procs.2020.01.049","journal-title":"Procedia Comput Sci"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-160560","article-title":"Development of a late-life dementia prediction index with supervised machine learning in the population-based CAIDE study","volume":"55","author":"Pekkala T","year":"2017","unstructured":"Pekkala T, Hall A, L\u00f6tj\u00f6nen J, et al.. Development of a late-life dementia prediction index with supervised machine learning in the population-based CAIDE study. J Alzheimers Dis. 2017, 55:1055-67. 10.3233\/JAD-160560","journal-title":"J Alzheimers Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/hbm.22522","article-title":"Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia","volume":"35","author":"Bron EE","year":"2014","unstructured":"Bron EE, Steketee RM, Houston GC, et al.. Diagnostic classification of arterial spin labeling and structural MRI in presenile early stage dementia. Hum Brain Mapp. 2014, 35:4916-31. 10.1002\/hbm.22522","journal-title":"Hum Brain Mapp"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/s21030778","article-title":"Brain asymmetry detection and machine learning classification for diagnosis of early dementia","volume":"21","author":"Herzog NJ","year":"2021","unstructured":"Herzog NJ, Magoulas GD. Brain asymmetry detection and machine learning classification for diagnosis of early dementia. Sensors (Basel). 2021, 21:10.3390\/s21030778","journal-title":"Sensors (Basel)"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-74399-w","article-title":"Multimodal deep learning models for early detection of Alzheimer's disease stage","volume":"11","author":"Venugopalan J","year":"2021","unstructured":"Venugopalan J, Tong L, Hassanzadeh HR, Wang MD. Multimodal deep learning models for early detection of Alzheimer's disease stage. Sci Rep. 2021, 11:10.1038\/s41598-020-74399-w","journal-title":"Sci Rep"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9072146","article-title":"A comprehensive machine-learning model applied to magnetic resonance imaging (MRI) to predict Alzheimer\u2019s disease (ad) in older subjects","volume":"9","author":"Battineni G","year":"2020","unstructured":"Battineni G, Chintalapudi N, Amenta F, Traini E. A comprehensive machine-learning model applied to magnetic resonance imaging (MRI) to predict Alzheimer\u2019s disease (ad) in older subjects. J Clin Med. 2020, 9:10.3390\/jcm9072146","journal-title":"J Clin Med"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-82098-3","article-title":"A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease","volume":"11","author":"El-Sappagh S","year":"2021","unstructured":"El-Sappagh S, Alonso JM, Islam SM, Sultan AM, Kwak KS. A multilayer multimodal detection and prediction model based on explainable artificial intelligence for Alzheimer's disease. Sci Rep. 2021, 11:10.1038\/s41598-021-82098-3","journal-title":"Sci Rep"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0253988","article-title":"Dementia risks identified by vocal features via telephone conversations: a novel machine learning prediction model","volume":"16","author":"Shimoda A","year":"2021","unstructured":"Shimoda A, Li Y, Hayashi H, Kondo N. Dementia risks identified by vocal features via telephone conversations: a novel machine learning prediction model. PLoS One. 2021, 16:10.1371\/journal.pone.0253988","journal-title":"PLoS One"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/4653923","article-title":"Machine learning for healthcare wearable devices: the big picture","volume":"2022","author":"Sabry F","year":"2022","unstructured":"Sabry F, Eltaras T, Labda W, Alzoubi K, Malluhi Q. Machine learning for healthcare wearable devices: the big picture. J Healthc Eng. 2022, 2022:10.1155\/2022\/4653923","journal-title":"J Healthc Eng"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11081437","article-title":"Alzheimer's disease and frontotemporal dementia: a robust classification method of EEG signals and a comparison of validation methods","volume":"11","author":"Miltiadous A","year":"2021","unstructured":"Miltiadous A, Tzimourta KD, Giannakeas N, Tsipouras MG, Afrantou T, Ioannidis P, Tzallas AT. Alzheimer's disease and frontotemporal dementia: a robust classification method of EEG signals and a comparison of validation methods. Diagnostics (Basel). 2021, 11:10.3390\/diagnostics11081437","journal-title":"Diagnostics (Basel)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.3389\/fdata.2021.613047","article-title":"Developing an explainable machine learning-based personalised dementia risk prediction model: a transfer learning approach with ensemble learning algorithms","volume":"4","author":"Danso SO","year":"2021","unstructured":"Danso SO, Zeng Z, Muniz-Terrera G, Ritchie CW. Developing an explainable machine learning-based personalised dementia risk prediction model: a transfer learning approach with ensemble learning algorithms. Front Big Data. 2021, 4:10.3389\/fdata.2021.613047","journal-title":"Front Big Data"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3390\/jpm10020031","article-title":"Application of machine learning technique to distinguish Parkinson's disease dementia and Alzheimer's dementia: predictive power of Parkinson's disease-related non-motor symptoms and neuropsychological profile","volume":"10","author":"Byeon H","year":"2020","unstructured":"Byeon H. Application of machine learning technique to distinguish Parkinson's disease dementia and Alzheimer's dementia: predictive power of Parkinson's disease-related non-motor symptoms and neuropsychological profile. J Pers Med. 2020, 10:10.3390\/jpm10020031","journal-title":"J Pers Med"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11112091","article-title":"The feasibility of differentiating Lewy body dementia and Alzheimer's disease by deep learning using ECD SPECT images","volume":"11","author":"Ni YC","year":"2021","unstructured":"Ni YC, Tseng FP, Pai MC, et al.. The feasibility of differentiating Lewy body dementia and Alzheimer's disease by deep learning using ECD SPECT images. Diagnostics (Basel). 2021, 11:10.3390\/diagnostics11112091","journal-title":"Diagnostics (Basel)"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1177\/0891988721993556","article-title":"A novel machine learning algorithm predicts dementia with Lewy bodies versus Parkinson's disease dementia based on clinical and neuropsychological scores","volume":"35","author":"Bougea A","year":"2022","unstructured":"Bougea A, Efthymiopoulou E, Spanou I, Zikos P. A novel machine learning algorithm predicts dementia with Lewy bodies versus Parkinson's disease dementia based on clinical and neuropsychological scores. J Geriatr Psychiatry Neurol. 2022, 35:317-20. 10.1177\/0891988721993556","journal-title":"J Geriatr Psychiatry Neurol"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23311-9","article-title":"Predicting optimal deep brain stimulation parameters for Parkinson's disease using functional MRI and machine learning","volume":"12","author":"Boutet A","year":"2021","unstructured":"Boutet A, Madhavan R, Elias GJ, et al.. Predicting optimal deep brain stimulation parameters for Parkinson's disease using functional MRI and machine learning. Nat Commun. 2021, 12:10.1038\/s41467-021-23311-9","journal-title":"Nat Commun"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01318-7","article-title":"Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence","volume":"10","author":"Signaevsky M","year":"2022","unstructured":"Signaevsky M, Marami B, Prastawa M, et al.. Antemortem detection of Parkinson's disease pathology in peripheral biopsies using artificial intelligence. Acta Neuropathol Commun. 2022, 10:10.1186\/s40478-022-01318-7","journal-title":"Acta Neuropathol Commun"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0236258","article-title":"Parkinson's disease detection from 20-step walking tests using inertial sensors of a smartphone: machine learning approach based on an observational case-control study","volume":"15","author":"Juutinen M","year":"2020","unstructured":"Juutinen M, Wang C, Zhu J, Haladjian J, Ruokolainen J, Puustinen J, Vehkaoja A. Parkinson's disease detection from 20-step walking tests using inertial sensors of a smartphone: machine learning approach based on an observational case-control study. PLoS One. 2020, 15:10.1371\/journal.pone.0236258","journal-title":"PLoS One"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2020.626154","article-title":"Deep learning-based classification and voxel-based visualization of frontotemporal dementia and Alzheimer's disease","volume":"14","author":"Hu J","year":"2020","unstructured":"Hu J, Qing Z, Liu R, et al.. Deep learning-based classification and voxel-based visualization of frontotemporal dementia and Alzheimer's disease. Front Neurosci. 2020, 14:10.3389\/fnins.2020.626154","journal-title":"Front Neurosci"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s11517-022-02630-z","article-title":"GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer's disease and frontotemporal dementia using genetic algorithms","volume":"60","author":"Garc\u00eda-Gutierrez F","year":"2022","unstructured":"Garc\u00eda-Gutierrez F, D\u00edaz-\u00c1lvarez J, Matias-Guiu JA, Pytel V, Mat\u00edas-Guiu J, Cabrera-Mart\u00edn MN, Ayala JL. GA-MADRID: design and validation of a machine learning tool for the diagnosis of Alzheimer's disease and frontotemporal dementia using genetic algorithms. Med Biol Eng Comput. 2022, 60:2737-56. 10.1007\/s11517-022-02630-z","journal-title":"Med Biol Eng Comput"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr037","article-title":"Training-related brain plasticity in subjects at risk of developing Alzheimer\u2019s disease","volume":"134","author":"Belleville S","year":"2011","unstructured":"Belleville S, Cl\u00e9ment F, Mellah S, Gilbert B, Fontaine F, Gauthier S. Training-related brain plasticity in subjects at risk of developing Alzheimer\u2019s disease. Brain. 2011, 134:1623-34. 10.1093\/brain\/awr037","journal-title":"Brain"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1016\/j.arr.2010.11.003","article-title":"Cognitive intervention for persons with mild cognitive impairment: a meta-analysis","volume":"10","author":"Li H","year":"2011","unstructured":"Li H, Li J, Li N, Li B, Wang P, Zhou T. Cognitive intervention for persons with mild cognitive impairment: a meta-analysis. Ageing Res Rev. 2011, 10:285-96. 10.1016\/j.arr.2010.11.003","journal-title":"Ageing Res Rev"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2318-11-55","article-title":"Cognitive and memory training in adults at risk of dementia: a systematic review","volume":"11","author":"Gates NJ","year":"2011","unstructured":"Gates NJ, Sachdev PS, Fiatarone Singh MA, Valenzuela M. Cognitive and memory training in adults at risk of dementia: a systematic review. BMC Geriatr. 2011, 11:10.1186\/1471-2318-11-55","journal-title":"BMC Geriatr"},{"key":"ref69","article-title":"Clinical study on a randomized, double-blind control of Shenwu gelatin capsule in treatment of mild cognitive impairment. [Article in Chinese]","volume":"32","author":"Zhong J","year":"2007","unstructured":"Zhong J, Tian J, Zhu A, Yang C. Clinical study on a randomized, double-blind control of Shenwu gelatin capsule in treatment of mild cognitive impairment. [Article in Chinese]. Zhongguo Zhong Yao Za Zhi. 2007, 32:1800-3.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2016.03.001","article-title":"2016 Alzheimer's disease facts and figures","volume":"12","author":"Alzheimer\u2019s Association","year":"2016","unstructured":"Alzheimer\u2019s Association. 2016 Alzheimer's disease facts and figures. Alzheimers Dement. 2016, 12:459-509. 10.1016\/j.jalz.2016.03.001","journal-title":"Alzheimers Dement"},{"key":"ref71","article-title":"Alzheimer disease","author":"Kumar A","year":"2023","unstructured":"Kumar A, Sidhu J, Goyal A, Tsao JW. Alzheimer disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s12559-021-09946-2","article-title":"Deep learning approach for early detection of Alzheimer's disease","volume":"14","author":"Helaly HA","year":"2022","unstructured":"Helaly HA, Badawy M, Haikal AY. Deep learning approach for early detection of Alzheimer's disease. Cognit Comput. 2022, 14:1711-27. 10.1007\/s12559-021-09946-2","journal-title":"Cognit Comput"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(03)92238-3","article-title":"P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer\u2019s disease: results from a one-year placebo-controlled study and two-year follow-up study","volume":"13","author":"Winblad B","year":"2003","unstructured":"Winblad B, Wimo A, Wetterholm A-L, et al.. P.4.044 Long-term efficacy of donepezil in patients with mild to moderate Alzheimer\u2019s disease: results from a one-year placebo-controlled study and two-year follow-up study. Eur Neuropsychopharmacol. 2003, 13:10.1016\/S0924-977X(03)92238-3","journal-title":"Eur Neuropsychopharmacol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.57.3.489","article-title":"A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD","volume":"57","author":"Winblad B","year":"2001","unstructured":"Winblad B, Engedal K, Soininen H, et al.. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology. 2001, 57:489-95. 10.1212\/wnl.57.3.489","journal-title":"Neurology"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1002\/gps.496","article-title":"Pharmacotherapy of Alzheimer\u2019s disease: is there a need to redefine treatment success?","volume":"16","author":"Winblad B","year":"2001","unstructured":"Winblad B, Brodaty H, Gauthier S, et al.. Pharmacotherapy of Alzheimer\u2019s disease: is there a need to redefine treatment success?. Int J Geriatr Psychiatry. 2001, 16:653-66. 10.1002\/gps.496","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1002\/gps.1133","article-title":"Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials","volume":"19","author":"Whitehead A","year":"2004","unstructured":"Whitehead A, Perdomo C, Pratt RD, Birks J, Wilcock GK, Evans JG. Donepezil for the symptomatic treatment of patients with mild to moderate Alzheimer's disease: a meta-analysis of individual patient data from randomised controlled trials. Int J Geriatr Psychiatry. 2004, 19:624-33. 10.1002\/gps.1133","journal-title":"Int J Geriatr Psychiatry"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1159\/000008243","article-title":"A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease","volume":"44","author":"Farlow M","year":"2000","unstructured":"Farlow M, Anand R, Messina J Jr, Hartman R, Veach J. A 52-week study of the efficacy of rivastigmine in patients with mild to moderately severe Alzheimer's disease. Eur Neurol. 2000, 44:236-41. 10.1159\/000008243","journal-title":"Eur Neurol"},{"key":"ref78","article-title":"Alzheimer\u2019s disease: early diagnosis and treatment","volume":"18","author":"Chu LW","year":"2012","unstructured":"Chu LW. Alzheimer\u2019s disease: early diagnosis and treatment. Hong Kong Med J. 2012, 18:228-37.","journal-title":"Hong Kong Med J"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.329593","article-title":"Frontotemporal dementia - current concepts","volume":"69","author":"Puppala GK","year":"2021","unstructured":"Puppala GK, Gorthi SP, Chandran V, Gundabolu G. Frontotemporal dementia - current concepts. Neurol India. 2021, 69:1144-52. 10.4103\/0028-3886.329593","journal-title":"Neurol India"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9080370","article-title":"Artificial intelligence models in the diagnosis of adult-onset dementia disorders: a review","volume":"9","author":"Battineni G","year":"2022","unstructured":"Battineni G, Chintalapudi N, Hossain MA, et al.. Artificial intelligence models in the diagnosis of adult-onset dementia disorders: a review. Bioengineering (Basel). 2022, 9:10.3390\/bioengineering9080370","journal-title":"Bioengineering (Basel)"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1007\/s11940-014-0319-0","article-title":"Treatment of frontotemporal dementia","volume":"16","author":"Tsai RM","year":"2014","unstructured":"Tsai RM, Boxer AL. Treatment of frontotemporal dementia. Curr Treat Options Neurol. 2014, 16:10.1007\/s11940-014-0319-0","journal-title":"Curr Treat Options Neurol"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/j.jalz.2009.04.1231","article-title":"Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: clinical observations as a basis for power calculations and safety analysis","volume":"6","author":"Liepelt I","year":"2010","unstructured":"Liepelt I, Gaenslen A, Godau J, Di Santo A, Schweitzer KJ, Gasser T, Berg D. Rivastigmine for the treatment of dementia in patients with progressive supranuclear palsy: clinical observations as a basis for power calculations and safety analysis. Alzheimers Dement. 2010, 6:70-4. 10.1016\/j.jalz.2009.04.1231","journal-title":"Alzheimers Dement"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.57.3.467","article-title":"Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy","volume":"57","author":"Litvan I","year":"2001","unstructured":"Litvan I, Phipps M, Pharr VL, Hallett M, Grafman J, Salazar A. Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy. Neurology. 2001, 57:467-73. 10.1212\/wnl.57.3.467","journal-title":"Neurology"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1034\/j.1600-0404.2001.103002123.x","article-title":"Donepezil in the treatment of progressive supranuclear palsy","volume":"103","author":"Fabbrini G","year":"2001","unstructured":"Fabbrini G, Barbanti P, Bonifati V, Colosimo C, Gasparini M, Vanacore N, Meco G. Donepezil in the treatment of progressive supranuclear palsy. Acta Neurol Scand. 2001, 103:123-5. 10.1034\/j.1600-0404.2001.103002123.x","journal-title":"Acta Neurol Scand"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410260318","article-title":"Physostigmine treatment of progressive supranuclear palsy","volume":"26","author":"Litvan I","year":"1989","unstructured":"Litvan I, Gomez C, Atack JR, Gillespie M, Kask AM, Mouradian MM, Chase TN. Physostigmine treatment of progressive supranuclear palsy. Ann Neurol. 1989, 26:404-7. 10.1002\/ana.410260318","journal-title":"Ann Neurol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1447-0594.2012.00956.x","article-title":"Pilot study of pharmacological treatment for frontotemporal dementia: risk of donepezil treatment for behavioral and psychological symptoms","volume":"13","author":"Kimura T","year":"2013","unstructured":"Kimura T, Takamatsu J. Pilot study of pharmacological treatment for frontotemporal dementia: risk of donepezil treatment for behavioral and psychological symptoms. Geriatr Gerontol Int. 2013, 13:506-7. 10.1111\/j.1447-0594.2012.00956.x","journal-title":"Geriatr Gerontol Int"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000231744.69631.33","article-title":"Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia","volume":"15","author":"Mendez MF","year":"2007","unstructured":"Mendez MF, Shapira JS, McMurtray A, Licht E. Preliminary findings: behavioral worsening on donepezil in patients with frontotemporal dementia. Am J Geriatr Psychiatry. 2007, 15:84-7. 10.1097\/01.JGP.0000231744.69631.33","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1159\/000113034","article-title":"Galantamine in frontotemporal dementia and primary progressive aphasia","volume":"25","author":"Kertesz A","year":"2008","unstructured":"Kertesz A, Morlog D, Light M, Blair M, Davidson W, Jesso S, Brashear R. Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord. 2008, 25:178-85. 10.1159\/000113034","journal-title":"Dement Geriatr Cogn Disord"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200421140-00003","article-title":"Rivastigmine in frontotemporal dementia: an open-label study","volume":"21","author":"Moretti R","year":"2004","unstructured":"Moretti R, Torre P, Antonello RM, Cattaruzza T, Cazzato G, Bava A. Rivastigmine in frontotemporal dementia: an open-label study. Drugs Aging. 2004, 21:931-7. 10.2165\/00002512-200421140-00003","journal-title":"Drugs Aging"},{"key":"ref90","article-title":"Parkinson disease","author":"Zafar S","year":"2023","unstructured":"Zafar S, Yaddanapudi SS. Parkinson disease. StatPearls [Internet]. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2017.12.003","article-title":"Parkinson's disease pathogenesis, evolution and alternative pathways: a review","volume":"174","author":"Alexoudi A","year":"2018","unstructured":"Alexoudi A, Alexoudi I, Gatzonis S. Parkinson's disease pathogenesis, evolution and alternative pathways: a review. Rev Neurol (Paris). 2018, 174:699-704. 10.1016\/j.neurol.2017.12.003","journal-title":"Rev Neurol (Paris)"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1016\/s0006-8993(99)01688-1","article-title":"Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist","volume":"838","author":"Iida M","year":"1999","unstructured":"Iida M, Miyazaki I, Tanaka K, Kabuto H, Iwata-Ichikawa E, Ogawa N. Dopamine D2 receptor-mediated antioxidant and neuroprotective effects of ropinirole, a dopamine agonist. Brain Res. 1999, 838:51-9. 10.1016\/s0006-8993(99)01688-1","journal-title":"Brain Res"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2007.12.001","article-title":"Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease","volume":"432","author":"Scheller D","year":"2008","unstructured":"Scheller D, Stichel-Gunkel C, L\u00fcbbert H, Porras G, Ravenscroft P, Hill M, Bezard E. Neuroprotective effects of rotigotine in the acute MPTP-lesioned mouse model of Parkinson's disease. Neurosci Lett. 2008, 432:30-4. 10.1016\/j.neulet.2007.12.001","journal-title":"Neurosci Lett"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-010-0214-3","article-title":"Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease","volume":"35","author":"Li C","year":"2010","unstructured":"Li C, Guo Y, Xie W, Li X, Janokovic J, Le W. Neuroprotection of pramipexole in UPS impairment induced animal model of Parkinson's disease. Neurochem Res. 2010, 35:1546-56. 10.1007\/s11064-010-0214-3","journal-title":"Neurochem Res"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1002\/mds.22218","article-title":"A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics","volume":"23","author":"Olanow CW","year":"2008","unstructured":"Olanow CW, Hauser RA, Jankovic J, et al.. A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): rationale, design, and baseline characteristics. Mov Disord. 2008, 23:2194-201. 10.1002\/mds.22218","journal-title":"Mov Disord"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1111\/cns.12727","article-title":"Adverse effects produced by different drugs used in the treatment of Parkinson's disease: a mixed treatment comparison","volume":"23","author":"Li BD","year":"2017","unstructured":"Li BD, Bi ZY, Liu JF, Si WJ, Shi QQ, Xue LP, Bai J. Adverse effects produced by different drugs used in the treatment of Parkinson's disease: a mixed treatment comparison. CNS Neurosci Ther. 2017, 23:827-42. 10.1111\/cns.12727","journal-title":"CNS Neurosci Ther"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2008.05.003","article-title":"Adverse events from the treatment of Parkinson's disease","volume":"26","author":"Chou KL","year":"2008","unstructured":"Chou KL. Adverse events from the treatment of Parkinson's disease. Neurol Clin. 2008, 26:S65-83. 10.1016\/j.ncl.2008.05.003","journal-title":"Neurol Clin"},{"key":"ref98","article-title":"Early treatment of Parkinson\u2019s disease: opportunities for managed care","volume":"18","author":"Murman DL","year":"2012","unstructured":"Murman DL. Early treatment of Parkinson\u2019s disease: opportunities for managed care. Am J Manag Care. 2012, 18:S183-8.","journal-title":"Am J Manag Care"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1177\/0004867419835029","article-title":"Dementia with Lewy bodies: challenges in the diagnosis and management","volume":"53","author":"Chin KS","year":"2019","unstructured":"Chin KS, Teodorczuk A, Watson R. Dementia with Lewy bodies: challenges in the diagnosis and management. Aust N Z J Psychiatry. 2019, 53:291-303. 10.1177\/0004867419835029","journal-title":"Aust N Z J Psychiatry"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1002\/alz.12334","article-title":"Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD)","volume":"17","author":"Galvin JE","year":"2021","unstructured":"Galvin JE, Chrisphonte S, Cohen I, et al.. Characterization of dementia with Lewy bodies (DLB) and mild cognitive impairment using the Lewy body dementia module (LBD-MOD). Alzheimers Dement. 2021, 17:1675-86. 10.1002\/alz.12334","journal-title":"Alzheimers Dement"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-444-64012-3.00005-8","article-title":"Behavioral symptomatology and psychopharmacology of Lewy body dementia","volume":"165","author":"Tampi RR","year":"2019","unstructured":"Tampi RR, Young JJ, Tampi D. Behavioral symptomatology and psychopharmacology of Lewy body dementia. Handb Clin Neurol. 2019, 165:59-70. 10.1016\/B978-0-444-64012-3.00005-8","journal-title":"Handb Clin Neurol"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1080\/13607863.2022.2032601","article-title":"Systematic review of pharmacological interventions for people with Lewy body dementia","volume":"27","author":"Watts KE","year":"2023","unstructured":"Watts KE, Storr NJ, Barr PG, Rajkumar AP. Systematic review of pharmacological interventions for people with Lewy body dementia. Aging Ment Health. 2023, 27:203-16. 10.1080\/13607863.2022.2032601","journal-title":"Aging Ment Health"},{"key":"ref103","article-title":"Early use of memantine in the treatment of Lewy body dementia. [Article in Dutch]","volume":"58","author":"Vanhaute H","year":"2016","unstructured":"Vanhaute H, Persoons P. Early use of memantine in the treatment of Lewy body dementia. [Article in Dutch]. Tijdschr Psychiatr. 2016, 58:814-7.","journal-title":"Tijdschr Psychiatr"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/192671-diagnostic-efficacy-and-clinical-relevance-of-artificial-intelligence-in-detecting-cognitive-decline","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:08Z","timestamp":1707509348000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/192671-diagnostic-efficacy-and-clinical-relevance-of-artificial-intelligence-in-detecting-cognitive-decline"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,13]]},"references-count":103,"URL":"https:\/\/doi.org\/10.7759\/cureus.47004","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10,13]]}}}